• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Salt ageusia in a patient with Crohn's disease treated with tumor necrosis factor antagonists.

作者信息

Collet Stéphanie, Rombaux Philippe, Rahier Jean-François

出版信息

Inflamm Bowel Dis. 2013 Apr;19(5):E73-4. doi: 10.1097/MIB.0b013e3182802b9c.

DOI:10.1097/MIB.0b013e3182802b9c
PMID:23407044
Abstract
摘要

相似文献

1
Salt ageusia in a patient with Crohn's disease treated with tumor necrosis factor antagonists.一名接受肿瘤坏死因子拮抗剂治疗的克罗恩病患者出现味觉缺失。
Inflamm Bowel Dis. 2013 Apr;19(5):E73-4. doi: 10.1097/MIB.0b013e3182802b9c.
2
Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.克罗恩病患儿中与英夫利昔单抗相关的银屑病可能需要停用抗肿瘤坏死因子治疗。
Inflamm Bowel Dis. 2013 Apr;19(5):E75-7. doi: 10.1097/MIB.0b013e3182802c93.
3
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.一名克罗恩病患者在英夫利昔单抗治疗过程中发生原发性胆汁性肝硬化：文献首例。
J Crohns Colitis. 2013 Oct;7(9):e397-8. doi: 10.1016/j.crohns.2013.03.003. Epub 2013 Apr 10.
4
Infliximab-induced psoriasis during therapy for Crohn's disease.英夫利昔单抗诱导的克罗恩病治疗期间的银屑病。
J Crohns Colitis. 2012 Jun;6(5):610-6. doi: 10.1016/j.crohns.2011.12.007. Epub 2012 Jan 26.
5
Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis.危及生命的播散性结核作为英夫利昔单抗治疗克罗恩病的并发症：两例报告，包括脑结核瘤和粟粒性结核。
J Crohns Colitis. 2012 Oct;6(9):946-9. doi: 10.1016/j.crohns.2012.02.018. Epub 2012 Jun 28.
6
Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset.克罗恩病患者骨质疏松的风险因素：英夫利昔单抗、皮质类固醇、体重指数和发病年龄。
Inflamm Bowel Dis. 2013 May;19(6):1173-8. doi: 10.1097/MIB.0b013e31828075a7.
7
[Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].[多发性硬化作为抗肿瘤坏死因子药物的不良反应：英夫利昔单抗治疗克罗恩病时罕见但重要的并发症]
Gastroenterol Hepatol. 2013 Feb;36(2):81-5. doi: 10.1016/j.gastrohep.2012.07.001. Epub 2012 Dec 4.
8
Multifocal-motor-neuropathy-like disease associated with Infliximab treatment in a patient with Crohn's disease.一名克罗恩病患者在接受英夫利昔单抗治疗后出现类似多灶性运动神经病的疾病。
J Neurol Sci. 2015 Feb 15;349(1-2):246-8. doi: 10.1016/j.jns.2015.01.003. Epub 2015 Jan 9.
9
Acute-severe fatigue after anti-TNFα treatment: an early insidious side effect.
J Crohns Colitis. 2013 Dec;7(12):e704-5. doi: 10.1016/j.crohns.2013.07.009. Epub 2013 Aug 13.
10
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.英夫利昔单抗治疗克罗恩病期间诱发的急性肝炎：与阿达木单抗无交叉毒性。
Gastroenterol Clin Biol. 2010 Sep;34(8-9):e7-8. doi: 10.1016/j.gcb.2010.01.016. Epub 2010 Feb 26.

引用本文的文献

1
World Workshop on Oral Medicine VII: Oral adverse effects to biologic agents in patients with inflammatory disorders. A scoping review.第七届世界口腔医学研讨会：炎症性疾病患者生物制剂的口腔不良反应。一项范围综述。
J Oral Pathol Med. 2023 Jan;52(1):1-8. doi: 10.1111/jop.13389. Epub 2022 Dec 13.